PrimeRFP SCOUT · Federal Contract Recompete Brief

HT942525FE062THIS SUPPLY purchase IS for 1 — Octapharma Usa Inc

Octapharma Usa Inc holds $9.2M across 8 federal awards, concentrated at Department of Defense (DOD). PoP ended Jan 16, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Army Med Res Acq Activity
Awarding office
Octapharma Usa Inc
Recipient
Jan 16, 2026
PoP end
$1.6M
Obligated
$1.6M
Potential
325414
NAICS
6515
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Octapharma Usa Inc — $90

Contract facts

Federal
Contract numberHT942525FE062
Also listed asHT942525DE004-HT942525FE062
AgencyArmy Med Res Acq Activity
Awarding officeArmy Med Res Acq Activity
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentOctapharma Usa Inc
CAGE484Y2
UEIFKJKNJVR1HV4
NAICS325414

No full NAICS 325414 intel page yet. Browse NAICS intelligence

PSC6515
Parent IDIQ / IDVHT942525DE004
Place of performanceTRAVIS AFB CA
Pricing typeFirm Fixed Price
Extent competedNot Available For Competition
Related solicitationHT942525Q0071
PoP startSep 16, 2025
PoP end (current)Jan 16, 2026
Obligated$1.6M
Current value$1.6M
Potential value$1.6M

THIS SUPPLY PURCHASE IS FOR 1,600 UNITS OF OCTAPLASLG KITS is a federal award for Army Med Res Acq Activity held by Octapharma Usa Inc. Estimated value $1.6M ($1.6M obligated). Current period of performance ends Jan 16, 2026. Place of performance: TRAVIS AFB CA. Related solicitation HT942525Q0071.

THIS SUPPLY PURCHASE IS FOR 1,600 UNITS OF OCTAPLASLG KITS

Recompete timing

Public
Past PoP end (217 days ago)

Current PoP ended Jan 16, 2026 (217 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Octapharma Usa Inc$9.2M obligated across 8 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)
Department of Defense (DOD)$9.2M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract HT942525FE062?

HT942525FE062 (THIS SUPPLY purchase IS for 1) is a Army Med Res Acq Activity award with a potential value of $1.6M, currently held by Octapharma Usa Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded HT942525FE062?

Army Med Res Acq Activity awarded HT942525FE062 to Octapharma Usa Inc (potential $1.6M).

Who is the incumbent on HT942525FE062?

Octapharma Usa Inc is the incumbent with $9.2M across 8 related awards in SCOUT’s public footprint. The current period of performance ends Jan 16, 2026.

When does Octapharma Usa Inc’s HT942525FE062 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 16, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HT942525FE062